In 2024, AI revolutionized drug development in the broader pharmaceutical landscape. Companies increasingly integrated AI to accelerate research, optimize clinical trials, and personalize patient care. This trend underscores the growing importance of AI-driven solutions in enhancing patient treatment efficiencies and outcomes. OM1 is at the forefront of this transformation – our award-winning, patented AI-powered digital phenotyping[…]
A complimentary suite of analytic reports for understanding the reasons behind medication discontinuation, patient outcomes, and prescribing behaviors. Introduction to Real-World Analytics Reasons for Discontinuation Report Comparative Outcomes Report Prescriber Trends Report Meet our Experts View the ebook >>
Bringing new treatments to market and delivering more precise care is challenging enough. Finding the data to support your programs shouldn’t be. This ebook explores powerful insights, analyses, and use cases from OM1’s Dermatology Network: Dermatologic diseases are complex. Getting valuable insights shouldn’t be. OM1 Dermatology Datasets Psoriasis Psoriatic Arthritis Alopecia Areata Atopic Dermatitis Hidradenitis[…]
OM1 Aspen enables life sciences organizations to automate real-world data collection and grow evergreen data networks, resulting in faster times to study launch, more complete and reliable data, and lower costs. In this ebook you will find: Key challenges Real-world data opportunities Use cases OM1 expertise View the ebook >>
Harness AI-powered digital phenotyping for personalized, predictive, and actionable insights in the PhenOM ebook. Meet PhenOM to learn how you can understand the patient journey from end to end: OM1 Orion: Pathfinder through patient journeys OM1 Lyra: Personalized insights at the point of care OM1 Polaris: Guiding research to the right patients Research & patient[…]
